TrialNature2026
Safety and efficacy of intratumoural anti-CTLA4 with intravenous anti-PD1.
Lambros Tselikas et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
TrialNature2026
Lambros Tselikas et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.